Muhammad Shaya Al-Badrani has been associated with reading “Okaz” 25 years ago, due to its credibility and analysis of news, and its keeping up with all the coverage that the Kingdom is witnessing in all regions. Al-Badrani is keen to own the "newspaper" daily, due to the diversity of its news in various fields.
Read next
Health
GLP-1 Class Drugs Drive Structural Shifts in Food and Healthcare Sectors
Widespread adoption of metabolic therapies impacts consumer packaged goods and chronic disease management.
Health
GLP-1 Receptor Agonists Alter Commercial Food and Beverage Demand Patterns
Widespread adoption of anti-obesity medications is reshaping consumer purchasing behaviors, pushing consumer packaged goods companies to reformulate product…
Health
Regulatory Pathways Accelerate Adoption of Generative AI in Diagnostic Radiology
Health authorities have updated approval criteria for algorithmic diagnostic software, shortening validation timelines for clinical deployments.
Health
GLP-1 Receptor Agonists Reframe Commercial Pharmaceuticals Market Strategy
Pharmaceutical manufacturers are reallocating R&D budgets toward metabolic therapies as clinical trial applications expand.
Health
A New Paradigm And The Law Of Attraction
In a period when it are so easy to obtain bogged down with daily life and feed off…
Health
Clinical Milestones Validate AI-Designed Molecules in Drug Discovery
Machine learning platforms are demonstrating reduced timelines in lead optimization, with several AI-designed compounds advancing to Phase II…